<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38287375</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Impaired influenza A virus replication by the host restriction factor SAMHD1 which inhibited by PA-mediated dephosphorylation of the host transcription factor IRF3.</ArticleTitle><Pagination><StartPage>33</StartPage><MedlinePgn>33</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-024-02295-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Influenza A virus (IAV) can cause severe and life-threatening illness in humans and animals. Therefore, it is important to search for host antiviral proteins and elucidate their antiviral mechanisms for the development of potential treatments. As a part of human innate immunity, host restriction factors can inhibit the replication of viruses, among which SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 (SAMHD1) can restrict the replication of viruses, such as HIV and enterovirus EV71. Viruses also developed countermeasures in the arms race with their hosts. There are few reports about whether SAMHD1 has a restriction effect on IAV.</AbstractText><AbstractText Label="METHODS">To investigate the impact of IAV infection on SAMHD1 expression in A549 cells, we infected A549 cells with a varying multiplicity of infection (MOI) of IAV and collected cell samples at different time points for WB and RT-qPCR analysis to detect viral protein and SAMHD1 levels. The virus replication level in the cell culture supernatant was determined using TCID50 assay. Luciferase assay was used to reveal that H5N1 virus polymerase acidic protein (PA) affected the activity of the SAMHD1 promoter. To assess the antiviral capacity of SAMHD1, we generated a knockdown and overexpressed cell line for detecting H5N1 replication.</AbstractText><AbstractText Label="RESULTS">In this study, we observed that SAMHD1 can restrict the intracellular replication of H5N1 and that the H5N1 viral protein PA can downregulate the expression of SAMHD1 by affecting SAMHD1 transcriptional promoter activity. We also found that SAMHD1's ability to restrict H5N1 is related to phosphorylation at 592-tyrosine.</AbstractText><AbstractText Label="CONCLUSIONS">In conclusion, we found that SAMHD1 may affect the replication of IAVs as a host restriction factor and be countered by PA. Furthermore, SAMHD1 may be a potential target for developing antiviral drugs.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhilei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Shuyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qingxun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Beijing Milu Ecological Research Center, Beijing, 100076, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Kening</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Salbia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Hongxuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China. hehx@ioz.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="D000076106">SAM Domain and HD Domain-Containing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494232">IRF3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="C484280">SAMHD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="Y">Influenza A virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053124" MajorTopicYN="Y">Influenza A Virus, H5N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076106" MajorTopicYN="N">SAM Domain and HD Domain-Containing Protein 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H5N1</Keyword><Keyword MajorTopicYN="N">Host restriction factor</Keyword><Keyword MajorTopicYN="N">Influenza virus</Keyword><Keyword MajorTopicYN="N">PA</Keyword><Keyword MajorTopicYN="N">SAMHD1</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38287375</ArticleId><ArticleId IdType="pmc">PMC10826253</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02295-0</ArticleId><ArticleId IdType="pii">10.1186/s12985-024-02295-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15–22. doi: 10.3201/eid1209.05-0979.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1209.05-0979</ArticleId><ArticleId IdType="pmc">PMC3291398</ArticleId><ArticleId IdType="pubmed">16494711</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn FL. Pandemic influenza in 1957; review of international spread of new Asian strain. J Am Med Assoc. 1958;166:1140–1148. doi: 10.1001/jama.1958.02990100028006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1958.02990100028006</ArticleId><ArticleId IdType="pubmed">13513331</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukumi H. Summary report on the Asian influenza epidemic in Japan, 1957. Bull World Health Organ. 1959;20:187–198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2537746</ArticleId><ArticleId IdType="pubmed">13651909</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CM, Shao C, Hou CC. Studies of strains of influenza viruses isolated during the epidemic in 1957 in Changchun. Vopr Virusol. 1957;2:278–281.</Citation><ArticleIdList><ArticleId IdType="pubmed">13530889</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockburn WC, Delon PJ, Ferreira W. Origin and progress of the 1968–69 Hong Kong influenza epidemic. Bull World Health Organ. 1969;41:345–348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2427756</ArticleId><ArticleId IdType="pubmed">5309437</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman JL, Kilbourne ED. Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A. 1969;63:326–333. doi: 10.1073/pnas.63.2.326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.63.2.326</ArticleId><ArticleId IdType="pmc">PMC223568</ArticleId><ArticleId IdType="pubmed">5257124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc. 2010;85:64–76. doi: 10.4065/mcp.2009.0588.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2009.0588</ArticleId><ArticleId IdType="pmc">PMC2800287</ArticleId><ArticleId IdType="pubmed">20007905</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16:47–60. doi: 10.1038/nrmicro.2017.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.118</ArticleId><ArticleId IdType="pubmed">29109554</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowson MA, Bresee JS, Global Seasonal Influenza-associated Mortality Collaborator N Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391:1285–1300. doi: 10.1016/S0140-6736(17)33293-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)33293-2</ArticleId><ArticleId IdType="pmc">PMC5935243</ArticleId><ArticleId IdType="pubmed">29248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayville LR. Influenza update: a review of currently available vaccines. P T. 2011;36:659–684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278149</ArticleId><ArticleId IdType="pubmed">22346299</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, Garcia-Sastre A. Influenza. Nat Rev Dis Primers. 2018;4:3. doi: 10.1038/s41572-018-0002-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-018-0002-y</ArticleId><ArticleId IdType="pmc">PMC7097467</ArticleId><ArticleId IdType="pubmed">29955068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa A, Abdelwhab EM, Mettenleiter TC, Pleschka S. Zoonotic potential of influenza A viruses: a comprehensive overview. Viruses. 2018;10:497. doi: 10.3390/v10090497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10090497</ArticleId><ArticleId IdType="pmc">PMC6165440</ArticleId><ArticleId IdType="pubmed">30217093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Zhu W, Yang L, Shu Y. The Epidemiology, Virology, and Pathogenicity of Human Infections with Avian Influenza Viruses. Cold Spring Harb Perspect Med. 2021;11:a038620. doi: 10.1101/cshperspect.a038620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a038620</ArticleId><ArticleId IdType="pmc">PMC8015695</ArticleId><ArticleId IdType="pubmed">31964651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowen AC. Constraints, drivers, and implications of influenza A virus reassortment. Annu Rev Virol. 2017;4:105–121. doi: 10.1146/annurev-virology-101416-041726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-101416-041726</ArticleId><ArticleId IdType="pubmed">28548881</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KY, Agu I, Jose I, Mantynen S, Campbell AJ, Mattson C, Chou TW, Zhou B, Gresham D, Ghedin E, Diaz Munoz SL. Influenza A virus reassortment is strain dependent. PLoS Pathog. 2023;19:e1011155. doi: 10.1371/journal.ppat.1011155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011155</ArticleId><ArticleId IdType="pmc">PMC10010518</ArticleId><ArticleId IdType="pubmed">36857394</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004;363:617–619. doi: 10.1016/S0140-6736(04)15595-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)15595-5</ArticleId><ArticleId IdType="pmc">PMC7112424</ArticleId><ArticleId IdType="pubmed">14987888</ArticleId></ArticleIdList></Reference><Reference><Citation>Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351:472–477. doi: 10.1016/S0140-6736(97)11212-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(97)11212-0</ArticleId><ArticleId IdType="pubmed">9482438</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 1998;279:393–396. doi: 10.1126/science.279.5349.393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.279.5349.393</ArticleId><ArticleId IdType="pubmed">9430591</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Horby PW, Tsang TK, Chen E, Gao L, Ou J, Nguyen TH, Duong TN, Gasimov V, Feng L, Wu P, Jiang H, Ren X, Peng Z, Li S, Li M, Zheng J, Liu S, Hu S, Hong R, Farrar JJ, Leung GM, Gao GF, Cowling BJ, Yu H. Differences in the epidemiology of human cases of avian influenza A(H7N9) and A(H5N1) viruses infection. Clin Infect Dis. 2015;61:563–571. doi: 10.1093/cid/civ345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/civ345</ArticleId><ArticleId IdType="pmc">PMC4542598</ArticleId><ArticleId IdType="pubmed">25940354</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li X, Lv X, Xu Q, Zhao Z, Qin S, Peng P, Qu F, Qin R, An Q, Wang M, Zhang Z, Luo H, Zeng X, Wang Y, Hou Z, Sun H, Wang Y, Xu Y, Li Y, Chai H. Highly pathogenic avian influenza A(H5Nx) virus of clade 2.3.4.4b emerging in Tibet, China, 2021. Microbiol Spectr. 2022;10:e0064322. doi: 10.1128/spectrum.00643-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00643-22</ArticleId><ArticleId IdType="pmc">PMC9241900</ArticleId><ArticleId IdType="pubmed">35446151</ArticleId></ArticleIdList></Reference><Reference><Citation>Anonymous. 2022. Assessment of risk associated with recent influenza A(H5N1) clade 2.3.4.4b viruses. https://www.who.int/publications/m/item/assessment-of-risk-associated-with-recent-influenza-a(h5n1)-clade-2344b-viruses.</Citation></Reference><Reference><Citation>Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL. Host immune response to influenza A virus infection. Front Immunol. 2018;9:320. doi: 10.3389/fimmu.2018.00320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00320</ArticleId><ArticleId IdType="pmc">PMC5845129</ArticleId><ArticleId IdType="pubmed">29556226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhou J, Mackintosh SG, Du Y. RuvB-like protein 2 interacts with the NS1 protein of influenza a virus and affects apoptosis that is counterbalanced by type i interferons. Viruses. 2021;13:1038. doi: 10.3390/v13061038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061038</ArticleId><ArticleId IdType="pmc">PMC8229658</ArticleId><ArticleId IdType="pubmed">34072766</ArticleId></ArticleIdList></Reference><Reference><Citation>Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, Fodor E. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol. 2010;84:8433–8445. doi: 10.1128/JVI.00879-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00879-10</ArticleId><ArticleId IdType="pmc">PMC2919034</ArticleId><ArticleId IdType="pubmed">20538852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5:439–449. doi: 10.1016/j.chom.2009.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.04.006</ArticleId><ArticleId IdType="pmc">PMC2737813</ArticleId><ArticleId IdType="pubmed">19454348</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol. 2012;86:8359–8366. doi: 10.1128/JVI.01122-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01122-12</ArticleId><ArticleId IdType="pmc">PMC3421771</ArticleId><ArticleId IdType="pubmed">22674996</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem. 2010;285:32064–32074. doi: 10.1074/jbc.M110.112458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.112458</ArticleId><ArticleId IdType="pmc">PMC2952208</ArticleId><ArticleId IdType="pubmed">20699220</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S, Hatta M, Kim JH, Le MQ, Neumann G, Kawaoka Y. Amino acid changes in the influenza A virus PA protein that attenuate avian H5N1 viruses in mammals. J Virol. 2014;88:13737–13746. doi: 10.1128/JVI.01081-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01081-14</ArticleId><ArticleId IdType="pmc">PMC4248959</ArticleId><ArticleId IdType="pubmed">25231317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Frandsen A, de Lucas S, Perez-Gonzalez A, Perez-Cidoncha M, Roldan-Gomendio A, Pazo A, Marcos-Villar L, Landeras-Bueno S, Ortin J, Nieto A. hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles. Sci Rep. 2016;6:20744. doi: 10.1038/srep20744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20744</ArticleId><ArticleId IdType="pmc">PMC4749964</ArticleId><ArticleId IdType="pubmed">26864902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A, Perez-Gonzalez A, Nieto A. Cellular human CLE/C14orf166 protein interacts with influenza virus polymerase and is required for viral replication. J Virol. 2011;85:12062–12066. doi: 10.1128/JVI.00684-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00684-11</ArticleId><ArticleId IdType="pmc">PMC3209284</ArticleId><ArticleId IdType="pubmed">21900157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu WB, Shih JL, Shih JR, Du JL, Teng SC, Huang LM, Wang WB. Cellular protein HAX1 interacts with the influenza A virus PA polymerase subunit and impedes its nuclear translocation. J Virol. 2013;87:110–123. doi: 10.1128/JVI.00939-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00939-12</ArticleId><ArticleId IdType="pmc">PMC3536397</ArticleId><ArticleId IdType="pubmed">23055567</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16:423–439. doi: 10.1038/s41579-018-0020-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0020-5</ArticleId><ArticleId IdType="pmc">PMC7097117</ArticleId><ArticleId IdType="pubmed">29769653</ArticleId></ArticleIdList></Reference><Reference><Citation>Riess M, Fuchs NV, Idica A, Hamdorf M, Flory E, Pedersen IM, Konig R. Interferons induce expression of SAMHD1 in monocytes through down-regulation of miR-181a and miR-30a. J Biol Chem. 2017;292:264–277. doi: 10.1074/jbc.M116.752584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.752584</ArticleId><ArticleId IdType="pmc">PMC5217685</ArticleId><ArticleId IdType="pubmed">27909056</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilakka-Kanthikeel S, Raymond A, Atluri VS, Sagar V, Saxena SK, Diaz P, Chevelon S, Concepcion M, Nair M. Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a. J Neuroinflammation. 2015;12:66. doi: 10.1186/s12974-015-0285-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0285-9</ArticleId><ArticleId IdType="pmc">PMC4410490</ArticleId><ArticleId IdType="pubmed">25890101</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Bonifati S, Qin Z, St Gelais C, Kodigepalli KM, Barrett BS, Kim SH, Antonucci JM, Ladner KJ, Buzovetsky O, Knecht KM, Xiong Y, Yount JS, Guttridge DC, Santiago ML, Wu L. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-kappaB and interferon pathways. Proc Natl Acad Sci U S A. 2018;115:E3798–E3807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910870</ArticleId><ArticleId IdType="pubmed">29610295</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, Ackroyd S, Allcock R, Bailey KM, Balottin U, Barnerias C, Bernard G, Bodemer C, Botella MP, Cereda C, Chandler KE, Dabydeen L, Dale RC, De Laet C, De Goede CG, Del Toro M, Effat L, Enamorado NN, Fazzi E, Gener B, Haldre M, Lin JP, Livingston JH, Lourenco CM, Marques W, Jr, Oades P, Peterson P, Rasmussen M, Roubertie A, Schmidt JL, Shalev SA, Simon R, Spiegel R, Swoboda KJ, Temtamy SA, Vassallo G, Vilain CN, Vogt J, Wermenbol V, Whitehouse WP, Soler D, Olivieri I, Orcesi S, Aglan MS, Zaki MS, et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 2013;12:1159–1169. doi: 10.1016/S1474-4422(13)70258-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70258-8</ArticleId><ArticleId IdType="pmc">PMC4349523</ArticleId><ArticleId IdType="pubmed">24183309</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011;474:654–657. doi: 10.1038/nature10117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10117</ArticleId><ArticleId IdType="pmc">PMC3595993</ArticleId><ArticleId IdType="pubmed">21613998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 2011;474:658–661. doi: 10.1038/nature10195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10195</ArticleId><ArticleId IdType="pmc">PMC3179858</ArticleId><ArticleId IdType="pubmed">21720370</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhang W, Cao X. Identification of human homologue of mouse IFN-gamma induced protein from human dendritic cells. Immunol Lett. 2000;74:221–224. doi: 10.1016/S0165-2478(00)00276-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-2478(00)00276-5</ArticleId><ArticleId IdType="pubmed">11064105</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Zhang D, Zhu M, Shen Y, Wei W, Ying S, Korner H, Li J. Roles of SAMHD1 in antiviral defense, autoimmunity and cancer. Rev Med Virol. 2017;27:e1931. doi: 10.1002/rmv.1931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1931</ArticleId><ArticleId IdType="pubmed">28444859</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutschmann J, Gramberg T. 2021. SAMHD1 ... and Viral Ways around It. Viruses 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7999308</ArticleId><ArticleId IdType="pubmed">33801276</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480:379–382. doi: 10.1038/nature10623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10623</ArticleId><ArticleId IdType="pubmed">22056990</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, St Gelais C, de Silva S, Yount JS, Tang C, Ji X, Shepard C, Xiong Y, Kim B, Wu L. SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity. Nat Med. 2016;22:1072–1074. doi: 10.1038/nm.4163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4163</ArticleId><ArticleId IdType="pmc">PMC5069697</ArticleId><ArticleId IdType="pubmed">27711056</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloglazova N, Flick R, Tchigvintsev A, Brown G, Popovic A, Nocek B, Yakunin AF. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J Biol Chem. 2013;288:8101–8110. doi: 10.1074/jbc.M112.431148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.431148</ArticleId><ArticleId IdType="pmc">PMC3605629</ArticleId><ArticleId IdType="pubmed">23364794</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Ryoo J, Oh C, Hwang S, Ahn K. SAMHD1 specifically restricts retroviruses through its RNase activity. Retrovirology. 2015;12:46. doi: 10.1186/s12977-015-0174-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-015-0174-4</ArticleId><ArticleId IdType="pmc">PMC4450836</ArticleId><ArticleId IdType="pubmed">26032178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim SY, Seo D, Kim J, White TE, Brandariz-Nunez A, Diaz-Griffero F, Yun CH, Hollenbaugh JA, Kim B, Baek D, Ahn K. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med. 2014;20:936–941. doi: 10.1038/nm.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3626</ArticleId><ArticleId IdType="pmc">PMC4318684</ArticleId><ArticleId IdType="pubmed">25038827</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, Kim SH, St Gelais C, Bonifati S, Li TW, Buzovetsky O, Knecht KM, Duchon AA, Xiong Y, Musier-Forsyth K, Wu L. SAMHD1 impairs HIV-1 gene expression and negatively modulates reactivation of viral latency in CD4(+) T Cells. J Virol. 2018;92:10–1128. doi: 10.1128/JVI.00292-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00292-18</ArticleId><ArticleId IdType="pmc">PMC6052313</ArticleId><ArticleId IdType="pubmed">29793958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong GU, Park IH, Ahn K, Ahn BY. Inhibition of hepatitis B virus replication by a dNTPase-dependent function of the host restriction factor SAMHD1. Virology. 2016;495:71–78. doi: 10.1016/j.virol.2016.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.05.001</ArticleId><ArticleId IdType="pubmed">27179347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenbaugh JA, Gee P, Baker J, Daly MB, Amie SM, Tate J, Kasai N, Kanemura Y, Kim DH, Ward BM, Koyanagi Y, Kim B. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog. 2013;9:e1003481. doi: 10.1371/journal.ppat.1003481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003481</ArticleId><ArticleId IdType="pmc">PMC3694861</ArticleId><ArticleId IdType="pubmed">23825958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ET, White TE, Brandariz-Nunez A, Diaz-Griffero F, Weitzman MD. SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J Virol. 2013;87:12949–12956. doi: 10.1128/JVI.02291-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02291-13</ArticleId><ArticleId IdType="pmc">PMC3838123</ArticleId><ArticleId IdType="pubmed">24067963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer AF, Riviere L, Qu B, Schott K, Riess M, Ni Y, Shepard C, Schnellbacher E, Finkernagel M, Himmelsbach K, Welzel K, Kettern N, Donnerhak C, Munk C, Flory E, Liese J, Kim B, Urban S, Konig R. Restrictive influence of SAMHD1 on Hepatitis B Virus life cycle. Sci Rep. 2016;6:26616. doi: 10.1038/srep26616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26616</ArticleId><ArticleId IdType="pmc">PMC4882586</ArticleId><ArticleId IdType="pubmed">27229711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe. 2013;14:422–434. doi: 10.1016/j.chom.2013.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.09.009</ArticleId><ArticleId IdType="pubmed">24139400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012;13:223–228. doi: 10.1038/ni.2236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2236</ArticleId><ArticleId IdType="pmc">PMC3771401</ArticleId><ArticleId IdType="pubmed">22327569</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell RD, Holland PJ, Hollis T, Perrino FW. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem. 2011;286:43596–43600. doi: 10.1074/jbc.C111.317628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C111.317628</ArticleId><ArticleId IdType="pmc">PMC3243528</ArticleId><ArticleId IdType="pubmed">22069334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballana E, Este JA. SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction. Trends Microbiol. 2015;23:680–692. doi: 10.1016/j.tim.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2015.08.002</ArticleId><ArticleId IdType="pubmed">26439297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YH, Jeang KT, Tokunaga K. Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology. 2012;9:112. doi: 10.1186/1742-4690-9-112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-9-112</ArticleId><ArticleId IdType="pmc">PMC3549941</ArticleId><ArticleId IdType="pubmed">23254112</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Huan C, Wang H, Liu Y, Liu X, Su X, Yu J, Zhao Z, Yu XF, Zheng B, Zhang W. TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity. EMBO Rep. 2020;21:e47528. doi: 10.15252/embr.201847528.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201847528</ArticleId><ArticleId IdType="pmc">PMC6944907</ArticleId><ArticleId IdType="pubmed">31797533</ArticleId></ArticleIdList></Reference><Reference><Citation>Cribier A, Descours B, Valadao AL, Laguette N, Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013;3:1036–1043. doi: 10.1016/j.celrep.2013.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.03.017</ArticleId><ArticleId IdType="pubmed">23602554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Li Z, Huan C, Liu X, Zhang W. SAMHD1 inhibits multiple enteroviruses by interfering with the interaction between VP1 and VP2 proteins. J Virol. 2021;95:e0062021. doi: 10.1128/JVI.00620-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00620-21</ArticleId><ArticleId IdType="pmc">PMC8316000</ArticleId><ArticleId IdType="pubmed">33883225</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C, Zhao Z, Wang S, Sun X, Zhang D, Sun X, Zhang A, Jin M. Influenza A virus PA antagonizes interferon-beta by interacting with interferon regulatory factor 3. Front Immunol. 2017;8:1051. doi: 10.3389/fimmu.2017.01051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01051</ArticleId><ArticleId IdType="pmc">PMC5600993</ArticleId><ArticleId IdType="pubmed">28955326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Zhan Y, Zhou Y, Jiang Y, Zheng X, Yu L, Tong W, Gao F, Li L, Huang Q, Ma Z, Tong G. Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity. Sci Rep. 2016;6:29665. doi: 10.1038/srep29665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29665</ArticleId><ArticleId IdType="pmc">PMC4944147</ArticleId><ArticleId IdType="pubmed">27411355</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers GN, Paulson JC. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology. 1983;127:361–373. doi: 10.1016/0042-6822(83)90150-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(83)90150-2</ArticleId><ArticleId IdType="pubmed">6868370</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Whittaker GR. Entry of influenza virus. Adv Exp Med Biol. 2013;790:72–82. doi: 10.1007/978-1-4614-7651-1_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-7651-1_4</ArticleId><ArticleId IdType="pubmed">23884586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KK. Architecture of a nascent viral fusion pore. EMBO J. 2010;29:1299–1311. doi: 10.1038/emboj.2010.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.13</ArticleId><ArticleId IdType="pmc">PMC2857459</ArticleId><ArticleId IdType="pubmed">20168302</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol. 1991;65:232–244. doi: 10.1128/jvi.65.1.232-244.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.65.1.232-244.1991</ArticleId><ArticleId IdType="pmc">PMC240510</ArticleId><ArticleId IdType="pubmed">1985199</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem. 1995;270:22701–22704. doi: 10.1074/jbc.270.39.22701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.39.22701</ArticleId><ArticleId IdType="pubmed">7559393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z, Liu T, Offringa DP, McInnis J, Levandowski RA. Association of influenza virus matrix protein with ribonucleoproteins. J Virol. 1999;73:7467–7473. doi: 10.1128/JVI.73.9.7467-7473.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.9.7467-7473.1999</ArticleId><ArticleId IdType="pmc">PMC104273</ArticleId><ArticleId IdType="pubmed">10438836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BJ, Leser GP, Morita E, Lamb RA. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol. 2007;81:7111–7123. doi: 10.1128/JVI.00361-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00361-07</ArticleId><ArticleId IdType="pmc">PMC1933269</ArticleId><ArticleId IdType="pubmed">17475660</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13:46–57. doi: 10.1038/nri3344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3344</ArticleId><ArticleId IdType="pmc">PMC3773942</ArticleId><ArticleId IdType="pubmed">23237964</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Banerjee S, Wang Y, Goldstein SA, Dong B, Gaughan C, Silverman RH, Weiss SR. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Proc Natl Acad Sci U S A. 2016;113:2241–2246. doi: 10.1073/pnas.1519657113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1519657113</ArticleId><ArticleId IdType="pmc">PMC4776461</ArticleId><ArticleId IdType="pubmed">26858407</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman AG, Smith JA, Balachandran S, Perwitasari O, Proll SC, Thomas MJ, Korth MJ, Barber GN, Schiff LA, Katze MG. The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol. 2007;81:2221–2230. doi: 10.1128/JVI.02151-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02151-06</ArticleId><ArticleId IdType="pmc">PMC1865913</ArticleId><ArticleId IdType="pubmed">17166899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol. 2000;74:6203–6206. doi: 10.1128/JVI.74.13.6203-6206.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.13.6203-6206.2000</ArticleId><ArticleId IdType="pmc">PMC112122</ArticleId><ArticleId IdType="pubmed">10846107</ArticleId></ArticleIdList></Reference><Reference><Citation>Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, Palese P. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol. 2011;85:2480–2491. doi: 10.1128/JVI.02188-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02188-10</ArticleId><ArticleId IdType="pmc">PMC3067929</ArticleId><ArticleId IdType="pubmed">21209114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, Chen L, Luo J, Wang B, Wang C, Li M, Huang C, Du J, Ma J, Chang Y, He H. Histone acetyl transferase TIP60 inhibits the replication of influenza a virus by activation the TBK1-IRF3 pathway. Virol J. 2018;15:172. doi: 10.1186/s12985-018-1079-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-018-1079-3</ArticleId><ArticleId IdType="pmc">PMC6225679</ArticleId><ArticleId IdType="pubmed">30409205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, Hao C, DeLucia M, Swanson S, Florens L, Washburn MP, Ahn J, Skowronski J. CyclinA2-cyclin-dependent kinase regulates SAMHD1 protein phosphohydrolase domain. J Biol Chem. 2015;290:13279–13292. doi: 10.1074/jbc.M115.646588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.646588</ArticleId><ArticleId IdType="pmc">PMC4505580</ArticleId><ArticleId IdType="pubmed">25847232</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>